Combination therapies for HER2

anneshirley

Combination therapies for HER2

anneshirley

I took this link from the HER2 support site for those of you who don't visit this site.  It's a discussion of some new trials coming up that will use a combination of HER2 therapies to block as many of the pathways of HER2 as possible. It's sounds encouraging! This was discussed this week at the Miami Breast Cancer Conference.  Please note that FireFox doesn't seem to work for this link, but Internet Explorer does.

 

http://www.cancerconf.com/media/2008./WEB/index.htm

lkc

Wow, thanks for posting this, Very encouraging news!

Zzap

Wow!

Very interesting, but a little worriesome for me since I'm on Tamoxifen.  I'd hate for it to be undoing any good my Herceptin did for me. 

Diana1993

I tried several times to bring up this link, with Internet Explorer, with no luck.  I get the site, but a blank screen.  I press play etc. and nothing. 

sherryw

I also thought the information was very interesting, but I didn't really understand the part about the tamoxifen either, it sounds like it would be counter productive.  I am on Fermara now, but I was on Tamoxifen when I was receiving my Herceptin treatments. 

It really sounds like they have hit on something good though.

sherry

anneshirley

I'm ER/PR negative so I didn't pay too much attention to the tamoxifen finding, and I'm not sure I totally understand.  The HER2 support site has lots of information about treatments.  If you don't belong you might want to and ask that question--about the tamoxifen.

Good luck to all of us.  I hope this really is something new and not the same old old.  They could inject me with ten drugs, on different days even, if I thought it would effect a cure. 

Sorry if IE is not working for you.  I had the same problem with Firefox, a blank screen, but then tried IE.  Perhaps your operating system is older?  Maybe use someone else's computer. 

Sassa

I am also ER/PR negative.

I found the information about Tamoxifen stimulating the surface estrogen receptors interesting.  Since stimulating those receptors increases the HER2 linking or the HER1 linking with the other HER sites, I am wondering if it will be eventually decided that being ER/PR- is better for outcome than being ER/PR+ when  HER2+.